SCHEMBL30830879

SCHEMBL30830879

CC(C)(C)OC(=O)N1CC(c2ccc(C3CCC(=O)NC3=O)cc2)C1

nearest known ligand 0.68

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 18/20 0.68
▸ DDB1 Q16531 17/20 0.68
▸ POLB P06746 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31232850 0.91 CRBN (0.63) CRBNDDB1POLB
SCHEMBL25187964 0.90 CRBN (0.67) CRBNDDB1POLBKDM4E
SCHEMBL23301622 0.90 CRBN (0.67) CRBNDDB1POLBKDM4E
SCHEMBL24206650 0.90 CRBN (0.67) CRBNDDB1POLBKDM4E
SCHEMBL30768901 0.87 CRBN (0.63) CRBNDDB1POLB
SCHEMBL29680843 0.86 CRBN (0.62) CRBNDDB1POLB
SCHEMBL26641267 0.85 CRBN (0.61) CRBNDDB1POLBKDM4E
SCHEMBL30643603 0.85 CRBN (0.61) CRBNDDB1POLBKDM4E
SCHEMBL29223642 0.84 CRBN (0.63) CRBNDDB1POLB
SCHEMBL29977218 0.84 DDB1 (0.64) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback